| Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer Y Liu, Z Chen, C Liu, D Yu, Z Lu, N Zhang Biomaterials 32 (22), 5167-5176, 2011 | 183 | 2011 |
| Expression profile and functional activity of peptide transporters in prostate cancer cells W Tai, Z Chen, K Cheng Molecular Pharmaceutics, 2012 | 93 | 2012 |
| Studies on bioadhesive PLGA nanoparticles: a promising gene delivery system for efficient gene therapy to lung cancer W Zou, C Liu, Z Chen, N Zhang International journal of pharmaceutics 370 (1-2), 187-195, 2009 | 93 | 2009 |
| Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis Z Chen, A Jain, H Liu, Z Zhao, K Cheng Journal of Pharmacology and Experimental Therapeutics, jpet. 118.256156, 2019 | 92 | 2019 |
| Preparation and characterization of cationic PLA-PEG nanoparticles for delivery of plasmid DNA W Zou, C Liu, Z Chen, N Zhang Nanoscale research letters 4 (9), 982-992, 2009 | 88 | 2009 |
| Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly (lactic acid)-poly (ethylene glycol) nanoparticles through caveolae … C Liu, W Yu, Z Chen, J Zhang, N Zhang Journal of Controlled Release, 2011 | 71 | 2011 |
| Biodegradable Tri-Block Copolymer Poly (lactic acid)-poly (ethylene glycol)-poly (l-lysine)(PLA-PEG-PLL) as a Non-Viral Vector to Enhance Gene Transfection C Fu, X Sun, D Liu, Z Chen, Z Lu, N Zhang International journal of molecular sciences 12 (2), 1371-1388, 2011 | 61 | 2011 |
| Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent Z Chen, D Yu, C Liu, X Yang, N Zhang, C Ma, J Song, Z Lu Journal of Drug Targeting 19 (8), 657-665, 2011 | 56 | 2011 |
| Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells Z Zhao, Y Li, A Jain, Z Chen, H Liu, W Jin, K Cheng Nanomedicine: Nanotechnology, Biology and Medicine 14 (1), 51-61, 2018 | 53 | 2018 |
| Discovery of PSMA-specific peptide ligands for targeted drug delivery W Jin, B Qin, Z Chen, H Liu, A Barve, K Cheng International journal of pharmaceutics 513 (1-2), 138-147, 2016 | 49 | 2016 |
| Discovery of Peptide Ligands for Hepatic Stellate Cells Using Phage Display Z Chen, W Jin, H Liu, Z Zhao, K Cheng Molecular pharmaceutics 12 (6), 2180-2188, 2015 | 44 | 2015 |
| Discovery of Aptamer Ligands for Hepatic Stellate Cells Using SELEX Z Chen, H Liu, A Jain, L Zhang, C Liu, K Cheng Theranostics 7 (12), 2982, 2017 | 43 | 2017 |
| Anionic solid lipid nanoparticles supported on protamine/DNA complexes J Ye, A Wang, C Liu, Z Chen, N Zhang Nanotechnology 19, 285708, 2008 | 43 | 2008 |
| Development of cholesteryl peptide micelles for siRNA delivery B Qin, Z Chen, W Jin, K Cheng Journal of Controlled Release 172 (1), 159-168, 2013 | 42 | 2013 |
| Biocompatible nanocomplexes for molecular targeted MRI contrast agent Z Chen, D Yu, S Wang, N Zhang, C Ma, Z Lu Nanoscale research letters 4 (7), 618-626, 2009 | 32 | 2009 |
| A Novel Rapamycin-Polymer Conjugate Based on a New Poly (Ethylene Glycol) Multiblock Copolymer W Tai, Z Chen, A Barve, Z Peng, K Cheng Pharmaceutical research 31 (3), 706-719, 2014 | 30 | 2014 |
| Novel cationic 6-lauroxyhexyl lysinate modified poly (lactic acid)–poly (ethylene glycol) nanoparticles enhance gene transfection C Liu, Z Chen, W Yu, N Zhang Journal of colloid and interface science 354 (2), 528-535, 2011 | 20 | 2011 |
| Silencing of α-complex protein-2 reverses alcohol-and cytokine-induced fibrogenesis in hepatic stellate cells H Liu, Z Chen, W Jin, A Barve, YJY Wan, K Cheng Liver research 1 (1), 70-79, 2017 | 19 | 2017 |
| Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy H Liu, Y Liu, Z Zhao, Y Li, B Mustafa, Z Chen, A Barve, A Jain, X Yao, G Li, ... Frontiers in Immunology 13, 2022 | 10 | 2022 |
| Assessment of Applications of Design of Experiments in Pharmaceutical Development for Oral Solid Dosage Forms G Bai, Z Chen, K Raines, H Chen, K Dave, HP Lin, BS Zolnik Journal of Pharmaceutical Innovation, 1-9, 2019 | 7 | 2019 |
Hao LiuUS Food and Drug AdministrationVerified email at mail.umkc.edu
